Rothschild Investment LLC’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.6M Sell
16,578
-311
-2% -$46.6K 0.1% 199
2026
Q1
$2.58M Buy
16,889
+106
+0.6% +$16.2K 0.13% 141
2025
Q4
$2.31M Buy
16,783
+6
+0% +$786 0.13% 143
2025
Q3
$2.15M Buy
16,777
+196
+1% +$23.9K 0.12% 150
2025
Q2
$2.01M Buy
16,581
+48
+0.3% +$5.41K 0.13% 148
2025
Q1
$1.84M Sell
16,533
-149
-0.9% -$15.9K 0.12% 153
2024
Q4
$1.62M Buy
16,682
+101
+0.6% +$10.8K 0.11% 164
2024
Q3
$1.91M Sell
16,581
-18
-0.1% -$2.04K 0.12% 151
2024
Q2
$1.77M Buy
16,599
+444
+3% +$44.6K 0.12% 147
2024
Q1
$1.56M Sell
16,155
-31
-0.2% -$3.18K 0.11% 158
2023
Q4
$1.63M Buy
16,186
+581
+4% +$56.1K 0.14% 132
2023
Q3
$1.59M Buy
15,605
+347
+2% +$35.2K 0.13% 148
2023
Q2
$1.54M Sell
15,258
-1,003
-6% -$100K 0.13% 151
2023
Q1
$1.5M Buy
16,261
+82
+0.5% +$7.16K 0.13% 154
2022
Q4
$1.47M Sell
16,179
-300
-2% -$25.3K 0.13% 157
2022
Q3
$1.25M Sell
16,479
-96
-0.6% -$7.96K 0.12% 170
2022
Q2
$1.4M Buy
16,575
+300
+2% +$26.3K 0.13% 166
2022
Q1
$1.43M Buy
16,275
+250
+2% +$21.6K 0.11% 181
2021
Q4
$1.4M Sell
16,025
-120
-0.7% -$9.96K 0.11% 179
2021
Q3
$1.32M Hold
16,145
0.11% 177
2021
Q2
$1.47M Buy
16,145
+24
+0.1% +$2.14K 0.12% 172
2021
Q1
$1.38M Hold
16,121
0.12% 176
2020
Q4
$1.52M Hold
16,121
0.15% 143
2020
Q3
$1.4M Hold
16,121
0.15% 136
2020
Q2
$1.41M Sell
16,121
-704
-4% -$60.8K 0.17% 129
2020
Q1
$1.39M Hold
16,825
0.18% 130
2019
Q4
$1.59M Hold
16,825
0.16% 144
2019
Q3
$1.46M Hold
16,825
0.17% 130
2019
Q2
$1.54M Sell
16,825
-3,291
-16% -$279K 0.18% 128
2019
Q1
$1.73M Buy
20,116
+335
+2% +$26.9K 0.2% 124
2018
Q4
$1.52M Hold
19,781
0.2% 120
2018
Q3
$1.53M Buy
19,781
+139
+0.7% +$10.3K 0.18% 127
2018
Q2
$1.33M Hold
19,642
0.17% 138
2018
Q1
$1.42M Sell
19,642
-9,597
-33% -$731K 0.18% 127
2017
Q4
$2.2M Buy
29,239
+6,194
+27% +$467K 0.24% 102
2017
Q3
$1.77M Sell
23,045
-166
-0.7% -$12.5K 0.2% 124
2017
Q2
$1.74M Sell
23,211
-253
-1% -$17.9K 0.2% 128
2017
Q1
$1.56M Sell
23,464
-1,299
-5% -$86.6K 0.18% 137
2016
Q4
$1.62M Sell
24,763
-200
-0.8% -$13K 0.19% 131
2016
Q3
$1.77M Sell
24,963
-316
-1% -$23K 0.22% 122
2016
Q2
$1.87M Sell
25,279
-474
-2% -$32.7K 0.24% 112
2016
Q1
$1.67M Sell
25,753
-279
-1% -$19K 0.22% 116
2015
Q4
$2.01M Hold
26,032
0.26% 102
2015
Q3
$2.14M Sell
26,032
-558
-2% -$49.7K 0.28% 92
2015
Q2
$2.34M Buy
26,590
+144
+0.5% +$13.2K 0.27% 97
2015
Q1
$2.34M Buy
26,446
+529
+2% +$46.9K 0.27% 95
2014
Q4
$2.15M Sell
25,917
-893
-3% -$74K 0.26% 92
2014
Q3
$2.26M Buy
26,810
+1,950
+8% +$158K 0.28% 88
2014
Q2
$2.02M Sell
24,860
-1,478
-6% -$116K 0.26% 100
2014
Q1
$2.01M Hold
26,338
0.27% 90
2013
Q4
$1.9M Sell
26,338
-725
-3% -$50.4K 0.26% 95
2013
Q3
$1.86M Hold
27,063
0.27% 91
2013
Q2
$1.72M Buy
+27,063
New +$1.76M 0.28% 90

Other funds holding NVS

Rothschild Investment LLC's NVS Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Novartis (NVS) stake by 1.8% in Q2 2026, selling an estimated $46.6K and leaving 16,578 shares worth $2.6M. The position accounts for 0.1% of the portfolio, ranked #199.

Rothschild Investment LLC first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. 941 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Rothschild Investment LLC held 16,578 shares of Novartis worth $2.6M as of Q2 2026.
  • Rothschild Investment LLC sold 311 Novartis shares in Q2 2026, an estimated $46.6K.
  • Novartis made up 0.1% of Rothschild Investment LLC's portfolio in Q2 2026, its #199 holding.
  • Rothschild Investment LLC first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
  • 941 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.